Prime Medicine (PRME) Payables: 2021-2025
Historic Payables for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $9.4 million.
- Prime Medicine's Payables rose 72.30% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year decrease of 6.49%. This contributed to the annual value of $11.4 million for FY2024, which is 41.90% down from last year.
- As of Q3 2025, Prime Medicine's Payables stood at $9.4 million, which was up 46.66% from $6.4 million recorded in Q2 2025.
- Over the past 5 years, Prime Medicine's Payables peaked at $19.5 million during Q4 2023, and registered a low of $1.4 million during Q4 2021.
- Moreover, its 3-year median value for Payables was $9.4 million (2025), whereas its average is $9.2 million.
- In the last 5 years, Prime Medicine's Payables soared by 350.99% in 2023 and then crashed by 61.56% in 2024.
- Prime Medicine's Payables (Quarterly) stood at $1.4 million in 2021, then soared by 201.88% to $4.3 million in 2022, then surged by 350.99% to $19.5 million in 2023, then tumbled by 41.90% to $11.4 million in 2024, then surged by 72.30% to $9.4 million in 2025.
- Its Payables stands at $9.4 million for Q3 2025, versus $6.4 million for Q2 2025 and $10.0 million for Q1 2025.